ストックスクリーナーアプリを入手
34.38
1.96%
-1.04
Viking Therapeutics Inc (VKTX) 最新ニュース
Viking Therapeutics: The Obesity Drugs Gold Rush Is Far From Over (NASDAQ:VKTX) - Seeking Alpha
Viking Therapeutics: A Tale of Clinical Momentum and Financial Strain - AD HOC NEWS
Here's How VKTX's Obesity Drug Is Moving Quickly Through Phase III - sharewise.com
Viking Therapeutics Accelerates Toward Pivotal Obesity Drug Data - AD HOC NEWS
Viking Therapeutics, Inc. $VKTX Shares Sold by Voya Investment Management LLC - MarketBeat
Viking Therapeutics Achieves Key Clinical Milestone Ahead of Schedule - AD HOC NEWS
Viking Therapeutics: A Wide-Open Oral GLP-1 Market (NASDAQ:VKTX) - Seeking Alpha
2 beaten-down stocks that could bounce back in 2026 - MSN
2 Beaten-Down Stocks That Could Bounce Back in 2026 - Finviz
The End of Shots? 5 Biotech Stocks Rethinking Diabetes - ADVFN
Viking Therapeutics: A High-Stakes Investment at a Critical Juncture - AD HOC NEWS
Viking Therapeutics, Inc. (VKTX) Sees a More Significant Dip Than Broader Market: Some Facts to Know - sharewise.com
Viking Therapeutics Shares Face Mounting Pressure - AD HOC NEWS
Insider Selling and Clinical Progress Shape Viking Therapeutics’ Stock Trajectory - AD HOC NEWS
Harbor Capital Advisors Inc. Trims Stock Holdings in Viking Therapeutics, Inc. $VKTX - MarketBeat
Viking Therapeutics: Investors Eye Pivotal Phase 3 Catalyst - AD HOC NEWS
Viking Therapeutics' Swing Trade Potential EmergesCompetition/Dilution Risks Remain (NASDAQ:VKTX) - Seeking Alpha
Price Action: Is Viking Therapeutics Inc. stock a good choice for value investorsMarket Volume Report & Real-Time Sentiment Analysis - moha.gov.vn
Viking Therapeutics, Inc. (VKTX) beats stock market upswing: What investors need to know - MSN
Market Moves: Is Viking Therapeutics Inc. stock a good choice for value investorsJuly 2025 Market Mood & Growth Focused Entry Reports - moha.gov.vn
Could Viking Therapeutics Become the Next Eli Lilly? - AOL.com
Why This Beaten-Down GLP-1 Stock Could Be a Steal - AOL.com
Here's How Much $100 Invested In Viking Therapeutics 5 Years Ago Would Be Worth Today - Sahm
Viking Therapeutics (VKTX) Is Up 8.9% After Rival Data Bolsters Its Oral Obesity Program - Yahoo Finance
Wall Street bulls look optimistic about Viking Therapeutics (VKTX): Should you buy? - MSN
Viking Therapeutics (VKTX): Revisiting Valuation After a Renewed Share Price Rally - simplywall.st
Viking Therapeutics, Inc. (VKTX) Beats Stock Market Upswing: What Investors Need to Know - sharewise.com
Wall Street Bulls Look Optimistic About Viking Therapeutics (VKTX): Should You Buy? - Finviz
(VKTX) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Viking Therapeutics, Inc. (NASDAQ:VKTX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
The Bull Case For Viking Therapeutics (VKTX) Could Change Following Fresh Validation Of Oral Obesity Drugs - simplywall.st
How to Buy Viking Therapeutics Stock (VKTX) - The Motley Fool
U.S. Capital Wealth Advisors LLC Buys 30,619 Shares of Viking Therapeutics, Inc. $VKTX - MarketBeat
Here is Why H.C. Wainwright Sees Immense Upside for Viking Therapeutics (VKTX) - Finviz
Here is why HC Wainwright sees immense upside for Viking Therapeutics (VKTX) - MSN
Profit Investment Management LLC Decreases Stock Position in Viking Therapeutics, Inc. $VKTX - MarketBeat
Viking Therapeutics, Inc. (VKTX) Rises Higher Than Market: Key Facts - MSN
Viking Therapeutics Stock Gains on Analyst Confidence and Pipeline Progress - AD HOC NEWS
Viking Therapeutics, Inc. (VKTX): A bull case theory - MSN
Published on: 2025-12-20 09:00:30 - ulpravda.ru
Analyst Confidence Fuels Viking Therapeutics Stock Rebound - AD HOC NEWS
Viking Therapeutics Inc. (VKTX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Viking Therapeutics: A Stock Poised Between High Conviction and High Short Interest - AD HOC NEWS
Chipmakers Recap: Is Viking Therapeutics Inc. stock a good choice for value investorsQuarterly Portfolio Report & Free Reliable Trade Execution Plans - Улправда
Viking Therapeutics Faces Intensifying Market Competition - AD HOC NEWS
Eli Lilly’s oral obesity drug passes maintenance test after Wegovy, Zepbound — Wall Street flags win for Viking Therapeutics - MSN
Analyst Confidence Soars for Viking Therapeutics with $102 Price Target - AD HOC NEWS
Why Viking Therapeutics Inc. stock remains undervaluedDividend Hike & Accurate Trade Setup Notifications - Улправда
Viking Therapeutics, Inc. (VKTX): A Bull Case Theory - Finviz
Eli Lilly’s Oral Obesity Drug Passes Maintenance Test After Wegovy, Zepbound — Wall Street Flags Win For Viking Therapeutics - Stocktwits
Viking Therapeutics: External Validation and Same-Molecule Strategy De-Risk Obesity Program, Supporting Buy Rating - TipRanks
Viking Therapeutics Stock Faces Technical Headwinds Despite Clinical Progress - AD HOC NEWS
Viking Therapeutics (VKTX): Assessing an Expensive Valuation After a Recent Pullback in the Share Price - simplywall.st
0.57%
1.48%
大文字化:
|
ボリューム (24 時間):